Use of Allied-health Professionals to Improve Treatment of Disease
- Sponsor
- University of Iowa
- Study ID
- NCT06337799
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Preeclampsia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- Research Pharmacist — BEHAVIORALThe goal of this intervention is to determine if allied health professionals will improve blood pressure in new mothers.
Study Details
The goal of this clinical trial is to learn if allied-health professionals can recruit and follow research participants, sustain engagement, and improve and diagnose treatment of diseases by facilitating transitions of care. Participants will: Take their blood pressure at home and return it to the research team; Follow up with a research pharmacist for 12 months; Return for a follow up visit after 12 months.
Key Dates
- First listed
- Mar 29, 2024
- Start date
- Oct 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Mar 31, 2030
- Completion
- Mar 31, 2030
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Research Pharmacist MonitoringThe research pharmacist will help the mother find a primary care physician if she doesn't have one and discuss strategies to lower blood pressure, if needed. The pharmacist interactions will occur 7 days after enrollment and then approximately every 2 weeks to 2 months during 12 months of follow up, depending on blood pressure control. They may recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed.
Primary Outcome Measure
Number of Subjects at Risk for Hypertension [ Time Frame: Through study completion, an average of 12 months ]
Central Contacts
- Philip M Polgreen, MD319-384-6194
- Shelby L Francis, PhD319-678-8037
Related Studies
- Effects of High Altitude on AMPK ActivationRecruiting · University of Colorado, Denver · Aurora, Colorado
- Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in PregnancyRecruiting · The George Washington University Biostatistics Center · Birmingham, Alabama
- Exosome Cargo From Preeclampsia PatientsRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Prenatal Aspirin and Postpartum Vascular FunctionEARLY_PHASE1 · Recruiting · Anna Stanhewicz, PhD · Iowa City, Iowa